Company Filing History:
Years Active: 2014
Title: André Korrat: Innovator in Tumor Response Prediction
Introduction
André Korrat is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of oncology through his innovative research and development. His work focuses on understanding how gene expression profiles can predict tumor responses to pharmaceutical compounds.
Latest Patents
André Korrat holds a patent titled "Gene expression profiles being predictive for the response of tumors to pharmaceutically effective compounds." This invention relates to a method for providing a gene expression profile that predicts the specific response of an individual tumor to a pharmaceutical compound. The patent includes the use of a microarray containing nucleotide sequences corresponding to predictive genes and a diagnostic kit that incorporates this microarray.
Career Highlights
Korrat is associated with Oncotest GmbH, a company dedicated to advancing cancer research and treatment. His work at Oncotest has been instrumental in developing methods that enhance the understanding of tumor behavior and treatment efficacy.
Collaborations
He collaborates with notable colleagues such as Niko Bausch and Heinz-Herbert Fiebig, contributing to a dynamic research environment focused on innovative cancer solutions.
Conclusion
André Korrat's contributions to the field of oncology through his patent and work at Oncotest GmbH highlight his role as a key innovator in predicting tumor responses to treatments. His research continues to pave the way for advancements in personalized medicine.